Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04477889 · ClinicalTrials.gov registry record
Methodist Health System COVID-19 Patient Registry
A clinical trial of COVID-19, sponsored by Methodist Health System.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04477889: Recruiting study of COVID-19, sponsored by Methodist Health System.
NCT04477889 is a study of COVID-19 that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 500 participants, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04477889, a study of COVID-19, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.
Primary Outcome
Patient characteristics
Conditions Studied
Interventions
- OTHER Treatment for COVID-19
Study Locations (1)
Texas
- Clinical Research Institute Methodist Health System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-06-20 |
| Est. Completion | 2026-12 |
What NCT04477889 shows while recruiting
NCT04477889 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Treatment for COVID-19 is the first listed.
NCT04477889 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04477889 about?
NCT04477889 is a clinical study titled "Methodist Health System COVID-19 Patient Registry". This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.
What is the current status of trial NCT04477889?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2020-06-20. Estimated completion is 2026-12.
What conditions does trial NCT04477889 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT04477889?
The interventions under investigation include: Treatment for COVID-19 (OTHER).
Who is sponsoring clinical trial NCT04477889?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04477889 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04477889's enrollment target sits among peer trials
500 111th of 298 higher than 186 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI